Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2005
03/03/2005WO2005019269A2 Techniques and compositions for the diagnosis and treatment of cancer (muc1)
03/03/2005WO2005019267A2 Tie1-binding ligands
03/03/2005WO2005019252A2 Novel fluorescent and colored proteins, and polynucleotides that encode these proteins
03/03/2005WO2005019250A1 Staphylococcus antibiotic peptides with a broad spectrum of action
03/03/2005WO2005019246A1 Coronavirus vaccines, therapeutics and diagnostics
03/03/2005WO2005019242A2 Recombinant expression of the hag1 antimicrobial peptide: use as fusion partner for the expression of alpha helical antimicrobial peptides
03/03/2005WO2005018673A1 Pharmaceutical composition for preventing or remedying cardiac hypertrophy and cardiocascular disease caused thereby
03/03/2005WO2005018650A2 Anti-bacterial composition, especially for controlling gram-negative bacteria, comprising a peptide and an advantageously hydrophobic anti-bacterial agent
03/03/2005WO2005018575A2 Estrogen receptor modulators and uses thereof
03/03/2005WO2005018571A2 Compositions and methods for treating inflammatory lung disease
03/03/2005WO2005018549A2 Methods and compositions for tissue repair
03/03/2005WO2005018537A2 Structure based and combinatorially selected oligonucleoside phosphorothioate and phosphorodithioate aptamer targeting ap-1 transcription factors
03/03/2005WO2005018534A2 Methods and compositions for rna interference
03/03/2005WO2005018331A1 Neurogenin3 and production of pancreatic islet cells
03/03/2005WO2005018307A1 Reduced-exposure tobacco products
03/03/2005WO2005005652A3 Methods for the identification of inhibitors of c4 long chain base hydroxylase activity in plants
03/03/2005WO2004113493A3 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site
03/03/2005WO2004111251A3 Modified fiber proteins for efficient receptor binding
03/03/2005WO2004110481A3 Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the listeria, and methods of use thereof
03/03/2005WO2004108071A3 Targeting polypeptides to the central nervous system
03/03/2005WO2004104032A3 Methods and compositions related to high-titer pseudotyped retroviruses
03/03/2005WO2004099243A8 Truncated forms of human dbf4, complexes with their interacting partners and methods for identification of inhibitors thereof
03/03/2005WO2004098647A3 Claudins’ underexpression as markers of tumor metastasis
03/03/2005WO2004093531A3 Generation of plants with altered oil content
03/03/2005WO2004092389A3 New process for improving the manufacture of clavams e.g. clavulanic acid
03/03/2005WO2004087956A3 Cell lines for the functional expression of nav1.8
03/03/2005WO2004087902A3 Novel plant acyltransferases specific for long-chained, multiply unsaturated fatty acids
03/03/2005WO2004072269A9 Bex4 nucleic acids, polypeptides, and method of using
03/03/2005WO2004072111A3 Novel therapeutic and diagnostic apoptotic inductors
03/03/2005WO2004069182A3 Active immunization to generate antibodies to soluble a-beta
03/03/2005WO2004067760A3 Xylose-fermenting recombinant yeast strains
03/03/2005WO2004062627A3 In vivo screening models for treatment of alzheimer's disease and other neurodegenerative disorders
03/03/2005WO2004031350A3 Modulation of forkhead box o1a expression
03/03/2005WO2004029212A3 In vivo gene silencing by chemically modified and stable sirna
03/03/2005WO2004025256A3 Viral deconstruction through capsid assembly in vitro
03/03/2005WO2004013312A3 Tocopherol biosynthesis related genes and uses thereof
03/03/2005WO2004002215A3 Genetic manipulation of condensed tannins
03/03/2005WO2004001058A3 Transcription factor modulating compounds and methods of use thereof
03/03/2005WO2004000876A8 INFECTIOUS cDNA OF AN APPROVED VACCINE STRAIN OF MEASLES VIRUS, USE FOR IMMUNOGENIC COMPOSITIONS
03/03/2005WO2003099219A3 Bryostatins, bryopyrans and polyketides: compositions and methods
03/03/2005WO2003078458A9 Tap-70, a novel marker for epithelial tumors
03/03/2005WO2003048349A3 Acetoacetyl-coa thiolase and use of for the identification of novel fungicidal substances
03/03/2005WO2003045317A3 Therapeutic protein and treatments
03/03/2005WO2003042362A3 PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR
03/03/2005US20050050602 Generating transgenic rice comprising expression vector which codes colony stimulating factor; bioreactors and heterologous gene expression
03/03/2005US20050050595 Novel compositions with chitinase activity
03/03/2005US20050050594 Enzyme inhibitors; competitive binding
03/03/2005US20050050591 Expression vector comprising nucleotide sequences coding mitotic regulatory proteins for use in enhancing formation of lateral organs, growth and yields of plants; tissue engineering and delayed senescence
03/03/2005US20050050590 Floral transition genes in maize and uses thereof
03/03/2005US20050050588 Phloem small RNA binding protein (PSRB) for use in enhancing plant growth, systemic resistance, biomass distribution and flowering
03/03/2005US20050050587 Inducers of plant disease resistance
03/03/2005US20050050586 AP1 amine oxidase variants
03/03/2005US20050050585 Via sequence encoding sinapyl alcohol dehydrogenase (SAD) that regulates the biosynthesis of lignin; papermaking
03/03/2005US20050050584 Transgenic plant cell comprising nucleotide sequences coding aminocyclpropane-1-carboxylate synthase for use as tool in modulating plant staygreen potential, sterility and ethylene synthesis and/or production
03/03/2005US20050050583 Compositions isolated from plant cells and their use in the modification of plant cell signaling
03/03/2005US20050050582 Promoter nucleotide sequences for use as tool in driving heterologous genic expression in seeds, pod walls, flower tissues and/or cells of plants
03/03/2005US20050050581 Expression vector comprising egg white protein regulatory sequences for use as tool in expression of heterologous gene sequences in oviduct cell of avians; tissue engineering; bioreactors
03/03/2005US20050050580 Transgenic animal expressing hla-a24 and utilization thereof
03/03/2005US20050050129 Method of estimating a penetrance and evaluating a relationship between diplotype configuration and phenotype using genotype data and phenotype data
03/03/2005US20050049793 Prenatal diagnosis method on isolated foetal cell of maternal blood
03/03/2005US20050049410 Expression vector comprising nucleotide sequences coding crystal protein for use as tool in controlling plant pest; pesticides; biological pest control
03/03/2005US20050049409 Novel human proteases and polynucleotides encoding the same
03/03/2005US20050049408 That retains the high RNA binding affinity of the parent oligonucleotide N3' --> P5' phosphoramidates and exhibits a much higher acid stability; inhibiting human telomerase enzyme activity; solid phase synthesis; kits
03/03/2005US20050049397 Dwarf-12 (DWF12) kinase for use in enhancing fertility of plants; tissue engineering and reproduction
03/03/2005US20050049395 Models of prion disease
03/03/2005US20050049230 Compounds that act to modulate insect growth and methods and systems for identifying such compounds
03/03/2005US20050049219 Methods of treatment with mini-dystrophin nucleic acid sequences
03/03/2005US20050049217 Stimulating the proliferation of kidney tubule epithelial cells in vivo using Zvegf4, a mitogenic multidomain protein with homology to the PDGF/VEGF family of growth factors; platelet-derived growth factor (PDGF); vascular endothelial growth factors (VEGF); renal failure
03/03/2005US20050049216 Immunostimulatory nucleic acid molecules
03/03/2005US20050049215 contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulating interferon-alpha to treat viral infections; oligonucleotide linked to a biodegradable delivery complex
03/03/2005US20050049214 Inhibition of E3-ubiquitin ligase HAKAI for treatment of proliferative disorders
03/03/2005US20050049212 Eating disorders, cachexia, diabetes mellitus, hypertension, coronary heart disease, hypercholesterolemia, osteoarthritis, gallstones, cancers of the reproductive organs, and sleep apnea; drug screening; diagnosis and therapy; kits; regulates metabolism of triglycerides
03/03/2005US20050049211 Oligonucleotides for treating hyperproliferative diseases such as cancer, inflammatory, developmental or metabolic disorders
03/03/2005US20050049201 Detection and removal of lead using lead-binding proteins
03/03/2005US20050049194 Use of ephrins and related molecules to regulate cellular proliferation
03/03/2005US20050049190 Cation conducting gabaa receptors and their use
03/03/2005US20050049189 Immunosuppressive protein for use in treatment and prevention of allergic, autoimmune, skin and respiratory disorders
03/03/2005US20050049188 G protein couple receptor for identifying modulators for treatment of cancers, infection, respiratory, nervous system, eating and pain disorders
03/03/2005US20050049186 Peptides mimicking the biological activity of steroid hormones and their uses
03/03/2005US20050049185 Gene encoding a multidrug-resistance human P-glycoprotein homologue on chromosome 7p15-2 and uses thereof
03/03/2005US20050048673 Method for detecting analyte(s) using magnetic colloidal particles
03/03/2005US20050048653 Non-linear amplitude dielectrophoresis waveform for cell fusion
03/03/2005US20050048652 Mini-retrotransposon vector for use as tool in transfer and expression of heterologous gene sequences in plants
03/03/2005US20050048650 Heterofunctional copolymers of glycerol and polyethylene glycol, their conjugates and compositions
03/03/2005US20050048649 Generating and identifying shuffled plasmid variants comprising linearizing circular plasmid, introduce plasmid into host cell, cultivating cell, screening for recombined gene sequences and polypeptides
03/03/2005US20050048647 Expression vector comprising short interfering RNA sequences for use as tool in controlling genic expression; gene therapy and gene expresssion inhibition; aimal models for disease
03/03/2005US20050048641 System and method for delivering polynucleotides to the central nervous system
03/03/2005US20050048639 Caspase-8 binding protein, its preparation and use
03/03/2005US20050048635 Polypeptides having oxaloacetate hydrolase activity and nucleic acids encoding same
03/03/2005US20050048633 Novel carbonyl reductase, gene encoding the same, and process for producing optically active alcohols using the same
03/03/2005US20050048632 Novel DNA encoding Eimeria glyceroaldehyde-3-phosphate dehydrogenase and uses thereof
03/03/2005US20050048631 Which have enhanced activity of enzymes involved in conversion of 5'-phosphoribosyl-4-carboxamide-5-aminoimidazole (AICAR) to inosine-5'-monophosphate (IMP), such as AICAR-transformylase-IMP cyclohydrolase
03/03/2005US20050048630 Nucleic acids encoding beta 1,4-N-acetylgalactosaminyltransferases from C. jejuni
03/03/2005US20050048629 theTat peptide is self cell-penetrating, is of HIV Type-1 and is bound to N-terminal amino acid residue of human parathyroid hormone-derived peptide; high stability and superior skin absorption; superior lipolysis effects and improved durability
03/03/2005US20050048628 Immunological binding molecules inhibiting the syncytial fusion of trophoblast
03/03/2005US20050048627 Tissue inhibitors of metalloproteinases (TIMP) for use in treatment and prevention of cell proliferative disorders; antitumor agents
03/03/2005US20050048625 Mammalian cytokines; related reagents and methods
03/03/2005US20050048624 Materials and methods for the modulation of cyclin-dependent kinase inhibitor-like polypeptides in maize
03/03/2005US20050048621 Using cytidine deaminase to generate variabilty in immunoglobulins; immunotherapy and directed protein evolution
03/03/2005US20050048617 Humanization of antibodies
1 ... 2067 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 2078 2079 2080 2081 2082 2083 2084 2085 2086 2087 ... 4023